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Abstract
 
Humoral immunity in the gut-associated lymphoid tissue is characterized by the production of
immunoglobulin A (IgA) by antibody-secreting plasma cells (PCs) in the lamina propria. The
chemokine CCL25 is expressed by intestinal epithelial cells and is capable of inducing chemo-
taxis of IgA
 
 
 
 PCs in vitro. Using a newly generated monoclonal antibody against murine
CCR9, we show that IgA
 
 
 
 PCs express high levels of CCR9 in the mesenteric lymph node
(MLN) and Peyer’s patches (PPs), but down-regulate CCR9 once they are located in the small
intestine. In CCR9-deficient mice, IgA
 
 
 
 PCs are substantially reduced in number in the lamina
propria of the small intestine. In adoptive transfer experiments, CCR9-deficient IgA
 
 
 
 PCs
show reduced migration into the small intestine compared with wild-type controls. Further-
more, CCR9 mutants fail to mount a regular IgA response to an orally administered antigen,
although the architecture and cell type composition of PPs and MLN are unaffected and are
functional for the generation of IgA PCs. These findings provide profound in vivo evidence
that CCL25/CCR9 guides PCs into the small intestine.
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Introduction
 
The gut acts as the port of entry for a vast array of foreign
antigens, including food components, but also potentially
harmful pathogens. A first line of defense against these antigens
is built by neutralizing immunoglobulins directed against
pathogens or toxins (1). For this purpose, antibody-secreting
plasma cells (PCs) of the lamina propria produce dimeric
IgA that is transported into the gut lumen by transcytosis
and bound to the mucus overlying the intestinal epithelium.
In the intestine, antigens are sampled by DCs located in
the epithelium or by specialized epithelia overlying Peyer’s
patches (PPs). In these follicle-associated epithelia, micro-
fold cells nonspecifically sample antigens from the gut lumen
and transport them to professional antigen-presenting cells
located in the subepithelial dome (SED; reference 2). To
elicit an immune response, these cells migrate into either
the adjacent interfollicular T cell zone, the B cell–rich follicles
of PPs, or even into the draining mesenteric lymph node
(MLN) to activate lymphocytes (3, 4). Some of the acti-
vated B cells start to proliferate and generate germinal
centers within PPs or MLN, which have been identified as
the places where affinity maturation and probably isotype
switch from IgM to IgA occurs. However, more recently it
has been shown that isotype switch of B220
 
 
 
 IgM
 
 
 
 cells at
least in part occurs in the lamina propria under the influence
of local stimuli (5). Most of the fully differentiated B cells
leave PPs and MLN and migrate via the lymphatics and the
thoracic duct into the blood and from there to the lamina
propria of the small intestine.
It has been proposed that signaling through the chemokine
receptor CCR9 might be an important factor that targets
cells to the intestine (6, 7). The CCR9 ligand CCL25/
TECK is expressed by epithelial cells of the small, but not
the large, intestine. CCR9 is expressed on virtually all small
intestinal T cells, and murine IgA-producing PCs from the
spleen, PPs, and MLN have been shown to migrate toward
CCL25 and CXCL12, a ligand for CXCR4 in vitro (8–10).
Notably, PCs of IgG or IgM isotype do not respond to
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CCL25 but migrate toward CXCL12 and CXCL9 (9, 11,
12), suggesting that the differential expression of chemokine
receptors targets PCs to their final destination depending on
the isotype of immunoglobulins they produce. Further-
more, during the course of a memory response, CXCR3
and CXCR4 have been implicated in guiding plasma blasts
to inflamed tissues or to the bone marrow, respectively (13).
In this report, we provide in vivo evidence that CCR9 is
crucial for the positioning of PCs to the small intestine.
 
Materials and Methods
 
Isolation of Lamina Propria Cells (LPCs) and Flow Cytometry.
 
Animals were bred at the animal facility of Hannover Medical
School under specific pathogen-free conditions. CCR9-deficient
mice have been described previously (14). In this analysis,
CCR9-deficient mice and littermates of a mixed genetic back-
ground were used. 8–10-wk-old animals were killed, and LPCs
were isolated using standard procedures.
Cells were stained using the following antibodies: anti-CD3-
PE (Caltag), IgA-biotin, CD19-biotin (Biosource International),
CD138-PE, B220-PerCP, IgM, and IgD (BD Biosciences). To
stain cytoplasmatic IgA, cells were fixed for 20 min in 2% PFA in
PBS on ice, washed, and resuspended for 20 min in 0.1% saponin
in PBS.
 
Generation of Monoclonal CCR9 Antibody.
 
A peptide compris-
ing amino acids 3–22 of mouse CCR9 was synthesized and cou-
pled to KLH or OVA. Rats were immunized subcutaneously and
intraperitoneally with a mixture of 50 
 
 
 
g peptide-KLH, 5 nmol
CPG oligonucleotide (Tib Molbiol), 500 
 
 
 
l PBS and 500 
 
 
 
l IFA
as described previously (15). Supernatants were tested by a differ-
ential ELISA and analyzed by flow cytometry using thymocytes
derived from wild-type and CCR9-deficient mice.
 
Immunofluorescence.
 
Immunohistological analysis of adult PPs
and MLN was done on cryosections as described previously (16).
For detection of CXCR4 (clone 2B11) and CCR9 (clone 7E7,
IgG2b), sections were blocked with mouse serum, incubated
with hybridoma supernatants, and detected using mouse anti–rat
Cy3 antibodies (Jackson ImmunoResearch Laboratories).
 
In Vivo Migration of BrdU-labeled Cells.
 
To label proliferating
cells in vivo, wild-type and CCR9-deficient animals were in-
jected intraperitoneally with 120 mg/kg BrdU (Sigma-Aldrich) in
PBS 1 h before killing. Cells were isolated from MLN and PPs,
and a total of 10
 
8
 
 cells was injected intravenously into wild-type
recipients. After 16 h, mice were killed, and the small intestine
was embedded in paraffin using standard procedures. Sections
were dewaxed, and BrdU-incorporated cells were detected using
the BrdU staining kit (Oncogene Research Products) and Cy3-
tyramid (NEN Life Science Products). IgA
 
 
 
 cells were identified
using anti-IgA FITC antibody (Caltag).
 
Oral OVA Immunizations and Serum Ig Analysis.
 
ELISA as-
says for total serum Ig levels were performed as described previ-
ously (16). Biotinylated anti-Ig antibodies were purchased from
BD Biosciences (anti-IgM, anti-IgG1, anti-IgG2a, anti-IgG2b,
and anti-IgG3) and Biosource International (anti-IgA).
10 mice per genotype were gavaged with 2.5 mg OVA and 10
 
 
 
g cholera toxin (CT) six times at 10-d intervals. For detection
of OVA-specific IgA and IgM antibodies, plates were coated
overnight with 5 
 
 
 
g/ml OVA, and appropriate dilutions of se-
rum samples were added (1:100–1:6,400). Anti–IgA-biotin and
anti–IgM-biotin followed by streptavidin-peroxidase and 5-thio-
2-nitrobenzoic acid were used for detection.
 
Results and Discussion
 
IgA
 
 
 
 PCs Express CCR9 Abundantly in Secondary Lym-
phoid Organs but Not the Small Intestine.
 
It has been sug-
gested that the interaction of CCL25 with CCR9 might
play an important role in the establishment of an IgA
 
 
 
 PC
pool in the small intestine. Therefore, we characterized the
expression of CCR9 on PCs in different organs with a
newly generated monoclonal antibody against CCR9. The
antibody displayed high levels of CCR9 on wild-type thy-
mocytes but not on thymocytes derived from CCR9-defi-
cient mice (Fig. 1 A).
In cell preparations isolated from the LPCs of wild-type
mice, two distinct populations of cells can be distinguished
based on size and granularity. Small LPCs are predomi-
nantly CD3
 
 
 
 lamina propria lymphocytes, whereas large
LPCs heavily stain with anti-IgA mAb after permeabiliza-
tion (unpublished data). Additionally, the majority these
cells show a CD138
 
 
 
, IgD
 
 
 
, IgM
 
 
 
, and CD19
 
 
 
 surface
phenotype and, thus, can be defined as lamina propria PCs
(unpublished data). CCR9 could be detected on most lam-
ina propria lymphocytes (Fig. 1 B), but more importantly,
only 
 
 
 
5% of all lamina propria PCs are CCR9
 
 
 
 (Fig. 1 C).
These observations were confirmed applying the CCR9
mAb in immunohistology. In contrast to IgA
 
 
 
 cells of
MLN and PPs, which showed high levels of CCR9 (Fig. 1
D and not depicted), the majority of IgA
 
 
 
 PCs of the small
intestine showed weak or undetectable staining with the
anti-CCR9 mAb (Fig. 1 E; compare with staining inten-
sity shown in Fig. 1 D). In addition, cells staining positive
for CCR9 seem to represent T cells (Fig. 1 E). Interest-
ingly, another chemokine receptor, CXCR4, was readily
detectable on all IgA
 
 
 
 PCs of all lymphoid organs exam-
ined, including PPs, MLN, and the small intestine (Fig. 1
F and not depicted). Because IgA
 
 
 
 PCs are known to
readily leave the place where they have been generated
(i.e., the secondary lymphoid organs), high expression of
CCR9 appears to be specific for newly generated PCs,
whereas this receptor becomes down-regulated once these
cells reached their final destination. These data suggest that
high levels of CCR9 are required for the homing of newly
generated IgA
 
 
 
 PCs to the intestine, whereas this receptor
seems to be dispensable for retaining PCs within this com-
partment. Because CXCR4 remains expressed on resident
IgA
 
 
 
 PCs within the intestine, it seems possible that
CXCR4 participates in this process. Indeed, data derived
from CXCR4-deficient mice suggest a role for this che-
mokine receptor in retaining PCs within lymphoid organs
such as bone marrow (11).
 
Reduced Numbers of PCs in the Intestinal Lamina Propria of
CCR9 Mutant Mice.
 
Based on these findings, we com-
pared the PC populations of wild-type and CCR9 mutant
mice by counting the number of IgA
 
 
 
 PCs on cryosec-
tions of the small intestine (Fig. 2, A and B). In this paper,
only villi were counted that were cut (judged on the anal-
ysis of serial sections) through the core of the villus. In
wild-type animals, an average of 20.6 
 
 
 
 1.2 (mean 
 
 
 
SEM) IgA
 
 
 
 cells per villus section was found. In contrast, 
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in CCR9 mutant mice, the number of PCs per villus sec-
tion was severely reduced to 11 
 
 
 
 1.1 (mean 
 
 
 
 SEM)
cells per villus section (Fig. 2 C). As an internal control,
the number of IgA
 
 
 
 DAPI
 
 
 
 LPCs was determined on the
same sections, revealing that CCR9 deficiency does not
affect cell types other than IgA
 
 
 
 PCs in this compartment
(Fig. 2 C, 19 
 
 
 
 0.9 cells vs. 22 
 
 
 
 1.6 cells). These results
could also be confirmed by flow cytometry on permeabi-
lized LPCs using an anti-IgA mAb that revealed a reduc-
tion of IgA
 
 
 
 PC numbers by 
 
 
 
50% in CCR9 mutants
(unpublished data).
Because it has been suggested that isotype switch can
take place in the lamina propria (5), we also used antibodies
specific for other immunoglobulin isotypes to detect differ-
ences between wild-type and CCR9 mutant mice. How-
ever, immunohistology for IgM and IgG did not reveal any
significant differences between both strains (unpublished
data), rendering it unlikely that impaired local isotype
switching accounts for the reduced number of IgA-positive
cells in CCR9 mutants. Furthermore, the phenotype of the
residual PC population in CCR9 mutants as determined by
expression of surface antigens (CD138, CD19, B220, IgA,
IgM, and IgD) was indistinguishable from that of wild-type
PCs, suggesting that loss of CCR9 does not affect the dif-
ferentiation of PCs.
Interestingly, in wild-type mice, most of the PCs locate
to the lower half of the villus (Fig. 2 C), which is the re-
gion where peak levels of CCL25 expression by the abut-
ting epithelial cells have been described previously (8), fur-
ther supporting the hypothesis that CCL25 signaling via
CCR9 contributes considerably to the efficient homing to
the small intestine. Most notably, no differences in the
number of IgA
 
 
 
 PCs were identified in the large intestine
of CCR9 mutants (wild type: 1 PC/4699 
 
 
 
 255 
 
 
 
m
 
2
 
;
CCR9 deficient: 1 PC/4832 
 
 
 
 331 
 
 
 
m
 
2
 
; 
 
n
 
 
 
  
 
5 animals
for each group). This observation is also in line with the re-
ported absence of CCL25 in the large intestine (8).
 
Reduced Homing Capacity of CCR9-deficient IgA
 
 
 
 PCs.
 
More than two decades ago, McDermott et al. identified
proliferating cells in MLN and PPs, but not in peripheral
LN, that were able to migrate into mucosal tissues and give
rise to IgA-secreting cells (17). To directly address the
function of CCR9 in this process, we labeled proliferating
cells using BrdU and isolated them from MLN and PPs of
wild-type and CCR9-deficient mice. 10
 
8
 
 cells were in-
jected i.v. into wild-type recipients, and after 16 h, the
Figure 1. CCR9 is expressed on all IgA  PCs in MLN but on few lamina
propria PCs. (A–C) Cells isolated from thymus (A) and small intestinal
lamina propria (B and C) of wild-type mice (solid line) and CCR9-deficient
animals (dashed line) were stained using a CCR9-specific monoclonal
antibody or an isotype control (shaded area). The histograms shown in B
were obtained by gating on small LPCs, whereas data shown in C were
obtained from large LPCs. (D–F) Three color immunohistology. Sections
of MLN (D) and small intestine (E and F) from wild-type mice were
stained with anti-CCR9 (D  and E , red) or anti-CXCR4 (F , red). Sections
were further stained with anti-IgA (D–F, green) and anti-CD3 (D’–F ,
blue). The three colors obtained from single sections have been separated
as depicted. Arrows indicate the position of IgA  PCs.
Figure 2. CCR9 mutant intestines harbor reduced numbers of IgA 
PC. Cryosections through the small intestine of wild-type (A) and
CCR9-targeted mice (B) were stained for IgA (red), CD3 (green), and
nuclei (blue). Unaltered numbers of IgA  cells were present in the lamina
propria of wild-type and CCR9 mutant animals, whereas numbers of
IgA  cells were reduced in CCR9 mutants (C, ***, P   0.001; data were
derived from five wild type and five mutants analyzing 60 villi each). 
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numbers of BrdU
 
 
 
 IgA
 
 
 
 PCs in the small intestine had
been determined. Interestingly, PCs from wild-type mice
were threefold more efficient in migrating into the small
intestine compared with cells derived from CCR9-defi-
cient mice (Fig. 3 A). These results contributed further
weight to the idea that CCR9 is required for efficient mi-
gration of newly formed PCs into the small intestine.
 
CCR9-deficient Mice Do Not Mount a Proper Immune
Response to Oral Antigens.
 
To test whether the reduced
number of IgA-secreting PCs observed in the intestine of
CCR9 mutants and the reduced migration efficiency of
IgA
 
 
 
 PCs are paralleled by reduced serum IgA levels, we
analyzed the amount of serum Ig in wild-type and CCR9
mutant mice. CCR9-deficient and wild-type mice were
not found to differ significantly with regard to normal se-
rum levels of any immunoglobulin isotypes tested (IgG1,
IgG2a, IgG2b, IgG3, IgM, and IgA), indicating that CCR9
is dispensable for systemic immunoglobulin production
(unpublished data).
Although the total amount of serum IgA was found to be
unchanged between wild-type and mutant mice, we were
interested to know whether differences exist between CCR9
mutants and wild-type mice in the induction of antigen-spe-
cific IgA response after oral immunization with a T cell–
dependent antigen. To this end, wild-type mice and CCR9
mutants were gavaged with 2.5 mg OVA and 10 
 
 
 
g CT at
10-d intervals. Serum levels of OVA-specific IgA were de-
termined 9 d after each single OVA application. In wild-type
animals, significant OVA-specific IgA levels were detectable
after three OVA applications that further increased after sub-
sequent applications of the antigen (Fig. 3 B). Interestingly,
in CCR9 mutants, a barely detectable increase in OVA-spe-
cific IgA titers could be determined within the period of time
analyzed, suggesting a severe impairment in the production
of OVA-specific IgA in these animals (Fig. 3 B).
 
Unaltered Architecture and Cell Composition of MLN and
PPs in CCR9-deficient Mice.
 
Because it is assumed that the
induction of an IgA-specific antibody response after oral
application of antigen plus CT requires antigen presenta-
tion within morphologically intact PPs and MLN, we fur-
ther analyzed both organs. We used immunohistology and
flow cytometry to identify possible alterations in cellular
composition or architecture of both organs in CCR9 mu-
tants that contained normal numbers of B and T cells, and
both cell types were located in their appropriate microen-
vironments. In addition, PPs contained normal numbers of
CD11c
 
 
 
, CD11b
 
 
 
, and CD11c
 
 
 
CD11b
 
 
 
 DCs (unpub-
lished data). Recently, it has been described that DCs of
the SED can be labeled and their path subsequently fol-
lowed using fluorescent latex beads (4). Because we found
CCR9-expressing cells, including DC within the SED
(unpublished data), we tested whether the mobilization of
DCs of the SED is affected in CCR9 mutants. Wild-type
and CCR9-deficient mice were deprived of water and
food for 4 h and subsequently gavaged with 10
 
12
 
 fluores-
cent latex beads (200 nm diameter; Polysciences) per ani-
mal. After 24 h, the mice were gavaged with 50 
 
 
 
g of CT.
After another 24 h, PPs and MLN were sectioned and
stained for CD11c and CD3 (Fig. 4, A–D, PPs only). In
wild type and CCR9 mutants, application of CT lead to
reduced numbers of CD11c
 
 
 
 cells (red) present in the SED
(Fig. 4, A–D). To quantify this effect, the absolute number
of fluorescent beads in the SED was counted in 20 PPs de-
rived from four wild type and four CCR9 mutants. In both
wild type and CCR9 mutants, CT administration triggers
an identical fivefold decrease of bead-labeled DCs localized
to the SED, suggesting that no differences in DC mobiliza-
tion exist and that the activation of naive B cells should
proceed normally in these CCR9
 
 
 
/
 
 
 
 organs (unpublished
data). Indeed, analysis of cryosections from MLN of wild-
type and mutant mice that were immunized five times with
OVA and CT revealed comparable numbers of IgA
 
 
 
 PCs
in both strains (Fig. 4, E and F). Furthermore, in wild type
and mutants likewise, the total numbers of IgA
 
 
 
 PCs
strongly increased after immunization in comparison to
nonimmunized mice (unpublished data) strongly support-
ing the idea that the generation of IgA PCs is not affected
by CCR9 deficiency.
The data provided in the present work demonstrate that
CCR9-deficient mice possess reduced numbers of IgA-
secreting PCs within the lamina propria, an observation
that correlates well with the reduced migration efficiency
of CCR9-deficient PCs into the small intestine and the in-
ability of these animals to mount a T-dependent antigen-
specific IgA response after oral application of antigen.
One hypothesis accounting for these defects would pos-
tulate the existence of a rather uniform PC population in-
side the small intestine. In this scenario, freshly generated
plasma blasts that express high levels of CCR9 gain effi-
cient entry into the intestinal lamina propria by CCL25-
mediated signaling, whereas the residual PC population in
CCR9-deficient mice would enter the lamina propria in-
Figure 3. CCR9 mutant PCs show an impaired migration into the
small intestine. (A) 16 h after adoptive transfer of BrdU-labeled cells iso-
lated from MLN and PP of wild-type and CCR9 mutant mice, the number
of BrdU  IgA  cells per villus was determined (*, P   0.05; data were
derived from three recipients of each group analyzing 60 villi each).
CCR9 mutant mice show a reduced humoral IgA response. (B) Groups
of 10 CCR9 mutants (solid line) and control animals (dashed line) were
each gavaged with OVA and CT at 10-d intervals, and serum levels of
OVA-specific IgA were measured. In contrast to wild-type animals showing
a robust increase of OVA-specific IgA levels, CCR9 mutants barely
produced OVA-specific IgAs. 
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dependent of CCR9, probably by a time-consuming and
inefficient bypass mechanism.
Alternatively, dependence on CCR9 signaling might re-
flect the different developmental fate and origin of PCs
populating the small intestine. It has been suggested that be-
sides conventional B2 cells, B1 cells from the peritoneal
cavity can give rise to lamina propria IgA
 
 
 
 PCs (18). How-
ever, this issue remains discussed controversially because in-
testinal IgA production in conventionally reared animals (as
performed in this work) has been shown to be the source of
almost exclusively B2, but not B1, cells (19). Unfortunately,
available immunological tools would not allow dissection of
B1 and B2 cell–derived PCs once they settled the lamina
propria. Interestingly, intraperitoneal immunization with T
cell–independent antigen results in a normal antigen-spe-
cific IgM response in CCR9 mutants, suggesting that B1
cell function per se is not affected in these animals (unpub-
lished data). Thus, a more likely explanation for the de-
crease of IgA
 
 
 
 PCs in CCR9 mutants is the less efficient re-
cruitment of B2 cell–derived PCs into the lamina propria in
the absence of CCR9 signaling. This idea is consistent with
a strongly reduced IgA response in orally immunized mice
assuming that antigen-specific PCs are generated in CCR9
mutants but fail to reach a compartment that supports secre-
tion and long-term survival of these cells.
In any case, CCR9-independent chemokine receptor
signaling would be required to guide the remaining PCs
into the lamina propria in CCR9-deficient mice, resulting
in serum and fecal IgA levels that do not significantly differ
from those present in wild-type animals (unpublished data).
Indeed, surface expression of CXCR4 can be detected on
IgA
 
 
 
 PCs (Fig. 1 F) consistent with the responsiveness of
these cells to CXCL12 in in vitro migration assays (9). Fur-
thermore, in humans, CCR10 has been documented in
PCs, including intestinal IgA
 
 
 
-secreting PCs (20), and we
were able to detect CCR10 expression in mouse PCs using
a CCL27-IgG
 
1
 
 fusion protein (unpublished data) suggesting
that CCR9 and CCR10 might cooperate in directing PCs
into the small intestine in mice. In conclusion, our findings
represent the first in vivo evidence that CCR9 is critical for
the homing of IgA-secreting PCs to the small intestine.
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